225 related articles for article (PubMed ID: 36171293)
1. Structure of the Ebola virus polymerase complex.
Yuan B; Peng Q; Cheng J; Wang M; Zhong J; Qi J; Gao GF; Shi Y
Nature; 2022 Oct; 610(7931):394-401. PubMed ID: 36171293
[TBL] [Abstract][Full Text] [Related]
2. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity.
Brown CS; Lee MS; Leung DW; Wang T; Xu W; Luthra P; Anantpadma M; Shabman RS; Melito LM; MacMillan KS; Borek DM; Otwinowski Z; Ramanan P; Stubbs AJ; Peterson DS; Binning JM; Tonelli M; Olson MA; Davey RA; Ready JM; Basler CF; Amarasinghe GK
J Mol Biol; 2014 May; 426(10):2045-58. PubMed ID: 24495995
[TBL] [Abstract][Full Text] [Related]
3. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
4. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E
Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725
[TBL] [Abstract][Full Text] [Related]
5. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
[TBL] [Abstract][Full Text] [Related]
7. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of de novo replication by the Ebola virus polymerase.
Peng Q; Yuan B; Cheng J; Wang M; Gao S; Bai S; Zhao X; Qi J; Gao GF; Shi Y
Nature; 2023 Oct; 622(7983):603-610. PubMed ID: 37699521
[TBL] [Abstract][Full Text] [Related]
9. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
[TBL] [Abstract][Full Text] [Related]
11. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
[TBL] [Abstract][Full Text] [Related]
12. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
Martin B; Canard B; Decroly E
Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
[TBL] [Abstract][Full Text] [Related]
13. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
14. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
15. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
16. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.
Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377
[TBL] [Abstract][Full Text] [Related]
17. Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis.
Luthra P; Jordan DS; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2015 May; 89(9):5148-53. PubMed ID: 25741013
[TBL] [Abstract][Full Text] [Related]
18. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.
Luthra P; Ramanan P; Mire CE; Weisend C; Tsuda Y; Yen B; Liu G; Leung DW; Geisbert TW; Ebihara H; Amarasinghe GK; Basler CF
Cell Host Microbe; 2013 Jul; 14(1):74-84. PubMed ID: 23870315
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain.
Leung DW; Shabman RS; Farahbakhsh M; Prins KC; Borek DM; Wang T; Mühlberger E; Basler CF; Amarasinghe GK
J Mol Biol; 2010 Jun; 399(3):347-57. PubMed ID: 20399790
[TBL] [Abstract][Full Text] [Related]
20. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]